178 related articles for article (PubMed ID: 12924612)
21. Efficacy of different low-density lipoprotein apheresis methods.
Parhofer KG; Geiss HC; Schwandt P
Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
[TBL] [Abstract][Full Text] [Related]
22. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
[TBL] [Abstract][Full Text] [Related]
23. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
25. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.
Makino H; Harada-Shiba M
Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.
Suzuki M; Yamane S; Matsugane T; Nobuto T; Azuma N; Nishide T; Shinomiya M; Saito K; Sasaki N; Nosé Y
Artif Organs; 1996 Apr; 20(4):296-302. PubMed ID: 8860710
[TBL] [Abstract][Full Text] [Related]
27. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
28. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
[TBL] [Abstract][Full Text] [Related]
29. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
30. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Olbricht CJ; Schoeppe E
Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746
[TBL] [Abstract][Full Text] [Related]
31. Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction.
Bosch T; Keller C
Ther Apher Dial; 2003 Jun; 7(3):341-4. PubMed ID: 12924610
[TBL] [Abstract][Full Text] [Related]
32. Apheresis technology for prevention and regression of atherosclerosis.
Yamamoto A; Harada-Shiba M; Kawaguchi A; Tsushima M
Ther Apher; 2001 Aug; 5(4):221-5. PubMed ID: 11724504
[TBL] [Abstract][Full Text] [Related]
33. Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.
Higashikata T; Mabuchi H
Ther Apher Dial; 2003 Aug; 7(4):402-7. PubMed ID: 12887722
[TBL] [Abstract][Full Text] [Related]
34. Differential indication of lipoprotein apheresis during pregnancy.
Klingel R; Göhlen B; Schwarting A; Himmelsbach F; Straube R
Ther Apher Dial; 2003 Jun; 7(3):359-64. PubMed ID: 12924613
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
[TBL] [Abstract][Full Text] [Related]
36. Current topics on low-density lipoprotein apheresis.
Bambauer R; Schiel R; Latza R
Ther Apher; 2001 Aug; 5(4):293-300. PubMed ID: 11724515
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
Zwiener RJ; Uauy R; Petruska ML; Huet BA
J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
[TBL] [Abstract][Full Text] [Related]
38. Low-density lipoprotein apheresis: principles and indications.
Winters JL
Semin Dial; 2012; 25(2):145-51. PubMed ID: 22277063
[TBL] [Abstract][Full Text] [Related]
39. Removal and recovery of cholesterol in thermofiltration.
Takeyama Y; Malchesky PS; Cressman MD; Yamashita M; Horiuchi T; Usami M; Koo AP; Pence G; Nose Y
Int J Artif Organs; 1988 May; 11(3):201-8. PubMed ID: 3403058
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Follow-Up of a Homozygous Familial Hypercholesterolemic Patient Receiving Regular Double Filtration Plasmapheresis - Case Report and Literature Review.
Tsai JL; Wu MJ; Shu KH; Tsai SF
Blood Purif; 2016; 41(4):264-9. PubMed ID: 26731699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
